Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 2
1978 2
1979 3
1981 3
1982 5
1983 2
1984 5
1985 4
1986 2
1987 5
1988 3
1989 4
1990 3
1991 2
1992 4
1993 3
1994 5
1995 2
1996 3
1997 3
1998 4
1999 3
2000 1
2001 3
2002 2
2003 3
2004 3
2005 2
2006 4
2007 3
2008 4
2012 1
2013 2
2014 5
2015 2
2016 2
2018 2
2020 1
2021 4
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66).
Yokoyama H, Araki SI, Yamazaki K, Kawai K, Shirabe SI, Oishi M, Kanatsuka A, Yagi N, Kabata D, Shintani A, Maegawa H; JDDM study group. Yokoyama H, et al. Among authors: kanatsuka a. BMJ Open Diabetes Res Care. 2022 May;10(3):e002727. doi: 10.1136/bmjdrc-2021-002727. BMJ Open Diabetes Res Care. 2022. PMID: 35504696 Free PMC article.
Patient characteristics associated with improvement in glycemic control following addition of an oral antidiabetic drug to DPP-4 inhibitor monotherapy in Japanese patients with type 2 diabetes mellitus (JDDM 60).
Kawai K, Eiki JI, Kanatsuka A, Motohashi S, Wakana A, Hayashi A, Iglay K, Yamazaki K, Tokita S, Maegawa H; Japan Diabetes Clinical Data Management Study Group (JDDM). Kawai K, et al. Among authors: kanatsuka a. Diabetol Int. 2021 Jul 15;13(1):132-141. doi: 10.1007/s13340-021-00514-5. eCollection 2022 Jan. Diabetol Int. 2021. PMID: 35059249 Free PMC article.
Fulminant type 1 diabetes: a nationwide survey in Japan.
Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Toyoda T, Maruyama T, Makino H. Imagawa A, et al. Among authors: kanatsuka a. Diabetes Care. 2003 Aug;26(8):2345-52. doi: 10.2337/diacare.26.8.2345. Diabetes Care. 2003. PMID: 12882860
Combination of disease duration-to-age at diagnosis and hemoglobin A1c-to-serum C-peptide reactivity ratios predicts patient response to glucose-lowering medication in type 2 diabetes: A retrospective cohort study across Japan (JDDM59).
Kanatsuka A, Sato Y, Higashi Y, Goto Y, Kawai K, Maegawa H; Japan Diabetes Data Management Study Group (JDDM). Kanatsuka A, et al. J Diabetes Investig. 2021 Nov;12(11):1967-1977. doi: 10.1111/jdi.13558. Epub 2021 May 12. J Diabetes Investig. 2021. PMID: 33837666 Free PMC article.
Secretion of islet amyloid polypeptide in response to glucose.
Kanatsuka A, Makino H, Ohsawa H, Tokuyama Y, Yamaguchi T, Yoshida S, Adachi M. Kanatsuka A, et al. FEBS Lett. 1989 Dec 18;259(1):199-201. doi: 10.1016/0014-5793(89)81527-3. FEBS Lett. 1989. PMID: 2689229 Free article.
113 results